Viracta Therapeutics (VIRX) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.35
-0.31
-0.27
-0.23

Details

Expected EPS
-0.3525
Actual EPS
-0.23
Surprise EPS
0.12
Surprise Percent
+34.75%

Description

⁨Viracta Therapeutics⁩ (⁦VIRX⁩) has reported earnings of ⁦-0.23⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts